A series of 1,2-bis(3‑butyl‑2,6-diphenylpiperidin-4-ylidiene)hydrazone derivatives of the substituted compounds 1–7, were confirmed by the characterization of IR & 1H-, NMR spectrum, together with X-ray crystallography and Mass spectroscopy also incredibly revealed. Docking analysis of the synthesized compounds employed under the protein from PDB code as 5cqh1, 4i40, 5fan, 7nud, 6Ya1 offers more inhibition values from 2D and 3D structures of the compounds, followed by Anti-cancer activity of the carcinoma cell line displayed that, highly potent to be active in nature. The in-vitro performance of -Cl substituted compound 6 (high anticancer activity) was in good correlation with its protein binding behaviour (strong binding). The increasing order of anticancer effect was 5>7>1>2>4>3>6 and the increasing order of binding ability on proteins were 7>3>4>1>2>5>6. The computational investigations were aligned with experimental techniques using Density Functional Theory (DFT) with a 6–31 G (d, p) basis set. Calculated Highest Occupied Molecular Orbital (HOMO) and Lowest Unoccupied Molecular Orbital (LUMO) energies revealed Mulliken charges and charge transfer phenomena occurring within the molecule. Analysis of the Molecular Electrostatic Potential (MEP) unveiled reactive sites, with high electron density regions depicted in red and low electron density regions in blue.
Read full abstract